IRCT20191022045196N1RecruitingPhase 2
Evaluating the effect of intranasal insulin administration on motor and non-motor symptoms in Parkinson’s disease patients; a randomized double-blinded placebo-controlled clinical trial
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 17 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Man and woman over 17 years old
- •Patient with Parkinson's disease according to UKPDSBB criteria
- •Provide written informed consent to participate in the study
- •Understand that they may withdraw their consent at any time.
Exclusion Criteria
- •1. Pregnant and lactating women
- •2. Patients with diabetes and taking anti-hyperglycemic drugs
- •3. Other neurodegenerative diseases like multiple system atrophy, Huntington's, Wilson's disease, Alzheimer's, ALS, progressive supranuclear palsy, etc.
- •4. Patients who cannot walk for more than one minute without help.
- •5. Patients with history of allergic reactions to insulin
- •6. Patients with history of nasal cavity inflammation that prevents insulin absorption
- •7. Patients with kidney and liver diseases
Investigators
Similar Trials
Recruiting
Phase 3
Efficacy trial of intranasal insuliElective cardiac surgery requiring cardiopulmonary bypassvalvular diseases, Ischemic heart diseasesJPRN-jRCTs031230047akadate Yosuke110
Completed
Not Applicable
Effect of intranasal insulin administering on patients with loss of smellIRCT2017061712782N15Vice chancellor for research,Isfahan University of Medical Sciences36
Completed
Phase 2
SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)Mild Cognitive ImpairmentAlzheimer's DiseaseNCT00438568University of Washington173
Completed
Phase 2
The effect of intranasal insulin on development and behaviour of children with Phelan-McDermid syndromeNL-OMON37136niversitair Medisch Centrum Groningen20
Active, not recruiting
Not Applicable
The effect of insulin nasal spray on development and behaviour of children with Phelan-McDermid syndromePhelan-McDermid syndromeEUCTR2012-002873-77-NLniversity Medical Center Groningen, Department of Genetics